|
| |
| | | 67881 | | 29.06.2021 | | iQone Healthcare Switzerland SA | | | | | | | 28.06.2026 | | | | | | | | 02.09.2022 | | 07.15. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Veblocema 120 mg | solution injectable en seringue préremplie | solution injectable en seringue préremplie (Infliximab 120 mg/ml) | L04AB02 | |
|
|
|
